The hardest part of recovery
isn't the injury.
It's everything that comes after.
LimbRise is here to help you write the next chapter.
I fell twice in the first week. The crutches slipped, I couldn't catch myself, and I left the hospital more injured than when I arrived.
I stopped going out. I couldn't carry anything, couldn't drive, couldn't shower alone. The injury took six weeks. The crutches took my independence.
My shoulders gave out before my knee even healed. My doctor said it was from the crutches. I traded one injury for two.
Insights from 69 real patient discovery interviews.
We heard their voices. Now it's our turn to act, and innovate for tomorrow.
We are innovating for a better tomorrow.
LimbRise is a Canadian medical technology company built on a single belief — recovery should give people their life back, not put it on hold. Every product we build starts with the patient, is validated with clinicians, and is designed for the real world.
Evidence-Based
Every decision backed by clinical research and real patient data.
Patient-Centered
Designed around how people actually live, not how clinicians treat.
Clinically Partnered
Built alongside physiotherapists, physicians, and research institutions.
One ecosystem. Built for the full recovery journey.
RevoStep
Hands-free. Patent-pending.
Rethinking how the body heals after knee injury. Designed for mobility. Built for real life.
- Hands-free from day one — no upper-body strain
- 0.98 m/s mobility — nearly double crutch speed
- Built for school, work, and real life
Reebound
AI-powered recovery coaching.
With you between every session. Because recovery doesn't pause when the clinic closes.
- A daily recovery score — the CRI
- AI coaching across fitness, nutrition, and rest
- Always on, between every session
One problem. Two answers. One ecosystem.
Two products, one mission — getting you back to your life. And we're only at the beginning.
The opportunity to rebuild recovery starts here.
A functional RevoStep prototype is built. Our $550K seed round opens September 2027 to fund the engineering and evidence required for the next stage.
Whether you're here to invest, to prescribe, or to partner — let's talk.
LimbRise is actively building its clinical partner network, and opening its $550K seed round in September 2027. If recovery matters to you — in any capacity — we want you in the conversation.